Author:
Kodama Yuichi,Fukano Reiji,Noguchi Maiko,Okamura Jun,Inagaki Jiro
Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Eng J Med. 1986;314:729–35.
2. Nevill TJ, Tirgan MH, Deeg HJ, Klingemann HG, Reece DE, Shepherd JD, et al. Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transpl. 1992;9:349–54.
3. Russell JA, Woodman RC, Poon MC, Jones AR, Ruether BA. Addition of low-dose folinic acid to a methotrexate/cyclosporine A regimen for prevention of acute graft-versus-host disease. Bone Marrow Transpl. 1994;14:397–401.
4. Peters C, Minkov M, Gadner H, Klingebiel T, Vossen J, Locatelli F, et al. Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children. Bone Marrow Transpl. 2000;26:405–11.
5. Ruutu T, Niederwieser D, Gratwohl A, Apperley JF. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT. Bone Marrow Transpl. 1997;19:759–64.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献